180 Life Sciences Corp
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
FRMM$2.88-5.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit No. | Description | Filed/ Furnished Herewith | Form | File No. | Exhibit | Filing Date |
|---|---|---|---|---|---|---|
| 3.1 | Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of 180 Life Sciences Corp., filed with the Secretary of State of Delaware on February 26, 2024 | 8-K | 001-38105 | 3.1 | 02/28/2024 | |
| 10.1# | Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D. | 8-K | 001-38105 | 10.1 | 01/17/2024 | |
| 10.2# | Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D. | 8-K | 001-38105 | 10.2 | 01/17/2024 | |
| 10.3# | Third Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Lawrence Steinman, M.D. | 8-K | 001-38105 | 10.3 | 01/17/2024 | |
| 10.4# | Second Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann | 8-K | 001-38105 | 10.4 | 01/17/2024 | |
| 10.5# | Second Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan | 8-K | 001-38105 | 10.1 | 02/16/2024 | |
| 10.6# | Second Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan | 8-K | 001-38105 | 10.2 | 02/16/2024 | |
| 10.7# | Offer Letter between 180 Life Science Corp. and Blair Jordan (director) dated February 24, 2024 and effective February 28, 2024 | 8-K | 001-38105 | 10.1 | 02/29/2024 | |
| 10.8# | Offer Letter between 180 Life Science Corp. and Omar Jimenez (director) dated March 4, 2024 and effective March 7, 2024 | 8-K | 001-38105 | 10.1 | 03/11/2024 | |
| 10.9# | Offer Letter between 180 Life Science Corp. and Ryan L. Smith (director) dated March 5, 2024 and effective March 7, 2024 | 8-K | 001-38105 | 10.2 | 03/11/2024 | |
| 10.10# | Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. James N. Woody | 8-K | 001-38105 | 10.1 | 05/9/2024 | |
| 10.11# | Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard | 8-K | 001-38105 | 10.2 | 05/9/2024 | |
| 10.12# | Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard | 8-K | 001-38105 | 10.3 | 05/9/2024 | |
| 10.13# | Fourth Amendment to Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman | 8-K | 001-38105 | 10.4 | 05/9/2024 | |
| 10.14# | Executive Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp., Blair Jordan and Blair Jordan Strategy and Finance Consulting Inc. | 8-K | 001-38105 | 10.5 | 05/9/2024 | |
| 10.15# | Form of 180 Life Sciences Corp. Indemnity Agreement | 8-K | 001-38105 | 10.6 | 05/9/2024 | |
| 16.1 | Letter from Marcum LLP dated April 19, 2024 | 8-K | 001-38105 | 16.1 | 04/19/2024 | |
| 31.1* | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act | X | ||||
| 31.2* | Certification of Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act | X | ||||
| 32.1** | Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act | X | ||||
| 32.2** | Certification of Principal Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act | X | ||||
| 101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema | X | ||||
| 101.CAL* | Inline XBRL Taxonomy Calculation Linkbase | X | ||||
| 101.DEF* | Inline XBRL Definition Linkbase Document | X | ||||
| 101.LAB* | Inline XBRL Taxonomy Label Linkbase | X | ||||
| 101.PRE* | Inline XBRL Definition Linkbase Document | X | ||||
| 104* | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set | X | ||||
| * | Filed herewith. |
|---|
| ** | Furnished herewith. |
|---|
| # | Indicates management contract or compensatory plan or arrangement. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.